Manuel Baader is an Investment Manager and Pharma Professional with over 20 years of experience in the industry. They are currently serving as a Board Director at HepaRegeniX GmbH, DiogenX, and EvlaBio, while also holding the position of Investment Manager at Boehringer Ingelheim Venture Fund. Previously, they were the Global Head of BD&L for CardioMetabolic Diseases at Boehringer Ingelheim and have held various leadership roles in research and development. Manuel studied at Universität Basel, where they are pursuing a Doctor of Philosophy (Ph.D.) in Medical Biological Research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices